Jafco Group: Announcements of individual stocks regarding the disposal of treasury stocks as a stock compensation system with transfer restrictions.
Jafco Group: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with transfer restrictions.
Jafco Group: Interim report
Jafco Group: Report on a large shareholding
Jafco Group: Corporate Governance Report
Jafco Group: Report on corporate governance as of June 19, 2024.
Jafco Group: Interim report
Jafco Group: Internal Control Report - 52nd period (April 1, 2023 - March 31, 2024)
Jafco Group: Confirmation letter
Jafco Group: Securities report - 52nd term (April 1, 2023 - March 31, 2024)
Jafco Group: Cordia Therapeutics Co., Ltd., a portfolio company of JAFCO, has been listed on the Tokyo Stock Exchange Growth Market.
Jafco Group: Chordia Therapeutics Co., Ltd., an investment target of our company, is newly listed on the Tokyo Stock Exchange's Growth Market.
Jafco Group: Investment in Atlas Corp Marshall Islands.
Jafco Group: Invested in Atlas Health Corporation.
Jafco Group: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Jafco Group: Astroscale Holdings Inc., a portfolio company of JAFCO, completed its IPO on the Tokyo Stock Exchange Growth Market.
Jafco Group: Astroscale Holdings Inc., an investment target of JAFCO, has made its debut on the Tokyo Stock Exchange Growth Market.
Jafco Group: We have invested in Forward Co., Ltd.
Jafco Group: Investment in Forward Co., Ltd.
Jafco Group: Independent Officer Notification Form
No Data